Individual Patient Expanded Access IND for the Treatment of Stroke

NO_LONGER_AVAILABLE

Conditions studied: Stroke, Stroke, Ischemic

In brief

This protocol is part of an Individual Patient Expanded Access IND. The patient is an 84-year-old male with history of Ischemic Stroke of the Left Middle Cerebral Artery causing an acute posterior left frontal cortical infarct with petechial hemorrhage and mild local mass effect without midline shift. The Stroke was due to a long-standing evolution of atrial fibrillation that provoked an embolus. The original stroke event happened on February/14/2022.

Key facts

Study ID

NCT04907188

Run by

Hope Biosciences Research Foundation

Last updated by the study team

2025-09-29

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Documented diagnosis Stroke.
• Hemodynamically stable.

You may not qualify if…

• Any signs of active infection at the time of screening.
• Subjects with coagulation disorders.
• Other acute or chronic medical conditions that, in the opinion of the investigator, may increase the risks associated with study participation or HB-adMSCs administration.
• Any abnormal, inexplicable laboratory result with no obvious cause defined.
• Participation in other interventional research studies.
• Unwillingness to return for follow-up visits.

Where it is running

• Hope Biosciences Stem Cell Research Foundation — Sugar Land, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.